Evidence map›Paper›PMID 36416290›Full record

ReviewChemical Society reviews2022

Carbon-based glyco-nanoplatforms: towards the next generation of glycan-based multivalent probes.

Javier Ramos-Soriano, Mattia Ghirardello, M Carmen Galan

Open access · hybridAbstract readReview
In one paragraph

Review in Chemical Society reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Javier Ramos-SorianoSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK. m.c.galan@bristol.ac.uk.ORCID http://orcid.org/0000-0002-3054-0679
Mattia GhirardelloSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK. m.c.galan@bristol.ac.uk.
M Carmen GalanSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK. m.c.galan@bristol.ac.uk.ORCID http://orcid.org/0000-0001-7307-2871
University of Bristol · GBUniversidad de La Rioja · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell surface carbohydrates mediate a wide range of carbohydrate-protein interactions key to healthy and disease mechanisms. Many of such interactions are multivalent in nature and in order to study these processes at a molecular level, many glycan-presenting platforms have been developed over the years. Among those, carbon nanoforms such as graphene and their derivatives, carbon nanotubes, carbon dots and fullerenes, have become very attractive as biocompatible platforms that can mimic the multivalent presentation of biologically relevant glycosides. The most recent examples of carbon-based nanoplatforms and their applications developed over the last few years to study carbohydrate-mediate interactions in the context of cancer, bacterial and viral infections, among others, are highlighted in this review.

Indexed as

Nanotubes, CarbonCarbohydratesGlycosidesPolysaccharidesCarbohydratesGlycosidesNanotubes, CarbonPolysaccharides

Identifiers

PMID36416290
PMCPMC9743786
OpenAlexW4310334259

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.